Global Resources Provide an International Advantage

Synteract brings a global focus to research projects through first-hand experience and collaboration with highly regarded and successful clinical trial management partners. Whether your projects require European, Eastern European, Latin American, Australian, or an Indian focus, we have partners around the globe who bring tremendous value and local expertise to every study. Our partners provide country specific expertise in: regulatory submissions, safety submissions, 24/7 medical monitoring services, drug depot management, along with outstanding clinical and project management services. As an extension of your staff, Synteract and our partners provide you with a global outsourcing solution for the conduct and completion of international trials of the highest quality.

FGK Clinical Research GmbH is a full service contract research organization offering a complete range of clinical development and consulting services to pharmaceutical, biotechnology and medical device companies. With more than 50 highly skilled and experienced people, FGK operates out of Munich on local and global projects, covering clinical studies from phases I to IV. FGK has extensive experience in all major therapeutic areas and clinical research fields. Synteract works with FGK to effectively design, manage and execute successful development programs and clinical trials.

The size of FGK and its experienced staff allows it to provide a complete range of clinical development services yet remain flexible enough to tailor services specifically to the exact needs of our clients, under Synteract’s direction. FGK is committed to quality, customized service and the protection of the client’s confidentiality.

Lifetree Clinical Research is a specialized research organization (SRO) of well trained research professionals. It has extensive experience and significant expertise in Phase I-III clinical trials and is widely recognized for its work in CNS, analgesia, abuse liability, sleep pathology, CSF and numerous other therapeutic areas. Lifetree provides Drug Development Services, Site Operational Services and Comprehensive Clinical Trial Management Services for the pharmaceutical and biotechnology industries.

Its Center of Excellence is a carefully designed investigative unit that supports the precise execution of projects and is committed to providing the highest quality, accuracy, timely completion and cost effectiveness in bringing drugs and devices to market. Lifetree’s flexibility and overall capability to implement immediate study changes, works to assist Synteract in providing phase I–III services with less overhead and proven, cost containment methods.

Medidata Solutions is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability.

Medidata’s advanced solutions address key functions throughout the clinical development process including protocol development, trial planning and management, user and learning management, randomization and trial supply management, monitoring, Serious Adverse Events capture and clinical data capture, management and reporting. As a Medidata channel partner, Synteract is accredited to deliver services to support the Medidata Rave® clinical trial technology along with comprehensive data management services and clinical expertise.

Founded in 1996, Novotech is the largest Australia based clinical CRO and the most experienced in participating in international clinical trials involving sites in Australia and New Zealand. Awarded as the current Australian CRO of the Year (by Frost & Sullivan), the company boasts a full service offering, including project management and monitoring, site and local vendor management, contract management, local sponsorship and regulatory affairs services.

Novotech’s end-to-end service means no local representation is required by clients in Australia or New Zealand, and clients can enjoy the streamlined regulatory process available to drug developers in that part of the world. In 2007, Novotech began extension of its services in the region, starting with operations in India and South Korea. As a Synteract partner, Novotech brings local environment expertise and a proven track record to clients in the Asia Pacific Region.

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Synteract partners with Phase Forward on a number of different types of projects. Phase Forward provides proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Empirica™ Trace), applied data standards (WebSDM™), and Phase I process automation (LabPas™).

Vince and Associates Clinical Research is a dedicated research facility that conducts Phase I-IV clinical trials for the global pharmaceutical and biotech industry. Vince and Associates has assembled an experienced team that focuses on quality research data and exceptional customer service while maintaining the highest ethical and professional standards. It has become one of the premier U.S. clinical research sites specializing in central nervous system research, one of the most rapidly growing segments in biopharmaceutical research. Vince and Associates also specializes in sleep disorders research, has expertise in conducting overnight and outpatient clinical trials. With over 200 clinical trials completed and having worked with over 70 sponsors and CROs, Vince and Associates is well known and respected for its rapid study start-up and excellent study data.

The Vince and Associates Clinical Research campus is made up of from a 12,000 square foot, Headquarters which focuses on Phase II-IV studies, 13,000 square foot, 50-bed Phase I Unit and a 10,000 square foot, 20-bed AASM Accredited Sleep Lab all located in Overland Park, Kansas - a part of the Kansas City metropolitan area with a population of nearly 2 million. From the 55 full-time staff dedicated to research to the up-scale facilities and amenities, Vince and Associates offers up a warm, inviting and positive experience that says: "Welcome to Clinical Research" like no other place can.